Ascent Industries Co. — Q1 2023 Form 10-Q
Business context and period: This unaudited report covers the three months ended March 31, 2023, compared with the same quarter of 2022. Ascent operates Tubular Products and Specialty Chemicals businesses.
Financial performance and position
| Metric | Q1 2023 | Q1 2022 / comparison |
|---|---|---|
| Net sales | $82.5 million | $116.2 million; down 29.1% |
| Gross profit and margin | $4.3 million; 5.2% | $22.5 million; 19.4% |
| Operating income (loss) | $(5.6) million | $13.2 million |
| Net income (loss) | $(5.2) million; $(0.51) per diluted share | $10.3 million; $0.99 per diluted share |
| Adjusted EBITDA, non-GAAP | $(1.6) million; (1.9)% of sales | $17.0 million; 14.6% of sales |
| Operating cash flow | $13.4 million | $0.4 million |
| Cash and cash equivalents | $0.4 million at March 31 | $1.4 million at December 31, 2022 |
| Debt | $58.7 million long-term debt, including current portion; total borrowings declined $12.9 million from year-end | — |
Quarter-end revolving credit availability was $50.0 million. The credit facility’s weighted-average interest rate was 6.62%; the company reported compliance with its debt covenants. The current ratio was 4.2, and debt to capital was 30%. Operating and finance lease liabilities totaled approximately $33.4 million. Capital expenditures were $0.8 million in the quarter; the company expected up to $4.9 million in spending for the remainder of 2023.
Operating cash flow was supported by working-capital movements, notably a $13.7 million inventory-related cash source and a $2.8 million increase in accounts payable. Investing activities used $0.8 million and financing activities used $13.6 million, including $80.4 million of debt repayments against $67.5 million of borrowings. Cash decreased by $1.0 million overall.
Material changes and operating drivers
- Sales fell mainly because pounds shipped declined 32.4%; average selling prices rose 5.8%. Management attributed a significant part of the volume decline to its decision to exit galvanized pipe and tube operations at the Munhall facility.
- Tubular Products sales decreased 33.6% to $58.7 million, with segment operating loss of $2.5 million versus $14.6 million of operating income a year earlier. Specialty Chemicals sales declined 14.3% to $23.7 million, and operating income fell to $1.4 million from $2.4 million.
- Management cited inflationary raw-material and manufacturing costs, reduced customer demand associated with inventory management, and higher SG&A. Consolidated SG&A rose to $9.6 million from $8.6 million; interest expense increased to $1.1 million from $0.4 million, primarily due to higher rates.
- Munhall asset recoverability testing following the change in planned use found the assets recoverable; no impairment was recorded. The company disposed of all remaining Palmer assets classified as held for sale during the quarter.
Outlook, risks, contingencies, and controls
- The filing provides no specific revenue or earnings guidance. Management said it was passing through input-cost increases where appropriate, managing working capital, and pursuing debt reduction and operational improvements. It stated that available liquidity was expected to fund operations, anticipated capital spending, and debt obligations over the next 12 months and beyond.
- Risks discussed include weaker demand, commodity and fuel price effects, inflation, supply-chain constraints, labor shortages, customer financial stability, and the ability to comply with debt covenants. Management reported no direct Russia or Ukraine operating exposure but was monitoring broader economic effects.
- A Henkel lawsuit against acquired subsidiary DanChem seeks approximately $3 million for alleged defective or non-conforming products and consequential damages. DanChem disputes liability; the company said it could not estimate a reasonably possible loss or range at this stage.
- Disclosure controls and procedures were assessed as ineffective at March 31, 2023 because previously reported material weaknesses in internal control over financial reporting remained unremediated. Remediation efforts include strengthening accounting and IT controls, staffing, documentation, and review procedures.
- The company repurchased 32,313 shares for approximately $0.3 million during the quarter. The board-authorized program had 647,666 shares remaining at March 31, 2023.
Important facts for investors to verify
- Whether lower shipment volumes and weak gross margins persist, and the pace and financial impact of the Munhall exit.
- Whether input-cost pass-throughs and operational actions restore profitability, particularly in Tubular Products.
- Liquidity, borrowing-base availability, interest costs, and covenant headroom under the variable-rate credit facility.
- Developments in the Henkel litigation and any subsequent estimate or recognition of a loss.
- Progress and testing results for remediation of the reported material weaknesses in internal controls.
- Actual 2023 capital spending compared with the stated expectation of up to $4.9 million for the remainder of the year.